Mergermarket analysts noted global M&A activity during the first quarter of 2018 culminated in a 17-year record high and signified the strongest start to the year since 2001, when the firm began recording data. The total value represents an 18 percent increase compared to M&A global deal value during the first quarter of 2017.
Analysts noted Amazon’s move into the pharmaceutical sphere last year served as a catalyst for dealmaking in the U.S. healthcare market, spurring several major pharmacy retailers to scoop up health plans, such as the $54 billion Cigna-Express Scripts acquisition, which was completed in March, and the proposed $69 billion acquisition of Aetna by Woonsocket, R.I.-based CVS Health, which CVS shareholders also approved last month.
M&A activity in the U.S. during the first quarter of 2018 represented 44.2 percent of the total global share of M&A activity during the period, according to the report.
To access the CNBC report, click here.
More articles on transactions and valuations:
2nd state entity OKs proposed Beth Israel Deaconess, Lahey Health merger
Summit Health, WellSpan Health to merge: 3 notes
UCHealth acquires 15-bed critical access hospital
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
